Concepedia

Bing Zhao

BZ

5

Publications

155

Citations

5

H-Index

2016

Active since

Affiliations

Fudan University(Current)

Shanghai Medical College of Fudan University

Fudan University Shanghai Cancer Center

Bing Zhao is an author at Fudan University specializing in thrombosis, biomedical engineering, and medicine.

ORCID

Top concepts

Publications per year

2016–2022

5

Publications

5

Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation

Bing Zhao, Meng‐Fang Wu, Zhihuang Hu et al. · Signal Transduction and Targeted Therapy · 2020 · 55 citations · Full text

Design and fabrication of r-hirudin loaded dissolving microneedle patch for minimally invasive and long-term treatment of thromboembolic disease

Meng‐Fang Wu, Tian Xia, Yaran Li et al. · Asian Journal of Pharmaceutical Sciences · 2022 · 35 citations · Full text

, , +15

A novel oncotherapy strategy: Direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non‐small cell lung cancer

Bing Zhao, Meng‐Fang Wu, Zhihuang Hu et al. · British Journal of Pharmacology · 2021 · 30 citations

RGD-hirudin-based low molecular weight peptide prevents blood coagulation via subcutaneous injection

Yaran Li, Yinong Huang, Bing Zhao et al. · Acta Pharmacologica Sinica · 2020 · 23 citations · Full text

, , +9

A novel hirudin derivative inhibiting thrombin without bleeding for subcutaneous injection

Bing Zhao, Yanling Zhang, Yinong Huang et al. · Thrombosis and Haemostasis · 2016 · 12 citations

Rows per page

1–5 of 5